---
title: "From Raw Data to Insight: Structuring Complexity"
author: "<br><br><span style='font-size:25px;'><strong>Lesley Chapman Hannah, Ph.D., M.S.</strong></span><br>College of Graduate Studies<br>Northeast Ohio Medical University"

format: 
  revealjs:
    #theme: solarized
    css: style.css
    slide-number: true
    chalkboard: 
      buttons: false
    preview-links: auto
    logo: images/Flame.jpg
    #css: styles.css
    
---

## <span style="font-size:80%">Lecture Outline</span> {.smaller}


- Review: turn high dimensional data into insight

  - Understand how complex, multi-variable analyses—such as gene expression, proteomic, or variant data—are distilled into interpretable biological patterns through plots

- Mapping relationships and biological connectivity through biological networks

  - Learn how network and pathway visualizations uncover the relational geometry of biological systems

- Aggregating evidence from high-dimensional data into pathways

  - Understand how pathway enrichment plots connect quantitative outcomes to biological mechanisms


::: footer

:::


## <span style="font-size:80%">Recap: High-dimensional [HD] Data Analysis</span> {.smaller}


Sources of HD data: 

- Arises from modern -omics, imaging, EHR, and wearable streams

- Millions of features per patient, making dimensionality reduction and organization essential for interpretation

- Transforms data complexity into perceivable structure—turns thousands of features into a spatial or conceptual map of biological systems

HD Analysis Strategy

- Dimensionality reduction reveals global structure—clusters, gradients, trajectories

- Reveals where patterns live but does not explain biological mechanism 

HD visualization reveals global structures:

- HD data visualization reveals connectivity between biologically features forming meaningful connections rarely driven by single genes or measurements

- Connectivity-based visuals that make these relationships visible: gene co-expression networks, functional modules, pathway cross-talk maps

::: footer

:::

## <span style="font-size:80%">Connecting Statistical Output to Biological Interpretation in High-Dimensional Data Analysis</span> {.smaller}


High-dimensional data analysis can produce thousands of statistical results: differential expression tests, feature correlations, variant associations numbers to interpret directly

Visualization transforms this statistical matrix into visual reasoning using the following two approaches:

- Networks $\rightarrow$ How do features relate?

- Pathways $\rightarrow$ What biological programs explain this pattern?


::: footer

:::


## <span style="font-size:80%">Connecting Statistical Output to Biological Interpretation in High-Dimensional Data Analysis</span> {.smaller}


High-dimensional data analysis can produce thousands of statistical results: differential expression tests, feature correlations, variant associations numbers to interpret directly

Visualization transforms this statistical matrix into visual reasoning using the following approaches:

- Networks $\rightarrow$ How do features relate?

  - In high-dimensional space, features (genes, proteins, variants) form co-expression or co-regulation modules

  - Network visualizations reduce dimensionality by mapping correlations into a perceivable structure — revealing functional neighborhoods within the data
  
  - Example: Thousands of genes/features $\rightarrow$ network modules reduce complexity by grouping correlated features into “neighbourhoods”



::: footer

:::



## <span style="font-size:80%">Connecting Statistical Output to Biological Interpretation in High-Dimensional Data Analysis</span> {.smaller}

::: columns
::: {.column width="50%"}


:::

::: {.column width="50%"}


![](images/figure_1.png){.border .border-thick}
:::
<span style="font-size:50%">Rolland, T. et al. Cell 159, 1212–1226 (2014)</span>
:::
::: footer
:::


## <span style="font-size:80%">Networks and Modules: Seeing Connectivity</span> {.smaller}


- In HD biology, relationships among features are often more important than the features themselves

- Gene co-expression networks reveal groups of genes that rise/fall together—suggesting shared regulatory control

- Protein–protein interaction (PPI) graphs identify modules that cooperate in signaling, metabolism, or immune activation

- Pathway maps collapse thousands of interacting genes into interpretable sub-networks.

- Visual encodings provide mechanistic meaning:

  - Color $\rightarrow$ module identity

  - Edge transparency $\rightarrow$ strength of correlation/interaction

  - Node size $\rightarrow$ importance (centrality, hubness)



::: footer

:::



## <span style="font-size:80%">Data Visualization for Gene Co-expression Networks</span> {.smaller}


**Biological Question**: How do genes within the same biological process—such as cytokine signaling, interferon response, or metabolic regulation—co-vary across samples, and which genes serve as key connectors within these processes?

**Data [simulated]**:

- 40 samples

- 15 genes

**Chart type**:

- network graph represents relationships (edges) between entities (nodes)

- Nodes $\rightarrow$ genes

- Edges $\rightarrow$ strong pairwise correlations in gene expression

**Goal(s)**:

- Reveal clusters or modules of genes that function together

- Highlight hub genes, which may regulate or integrate biological pathways


::: footer

:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Data Visualization for Gene Co-expression Networks</span> {.smaller}


::: columns
::: {.column .small}

**Plot Interpretation**:

- **Each point** (node) represents a gene
  
  - Point positions are derived from pairwise gene–gene correlations, so genes that behave similarly across patients or conditions appear closer together


- **Solid grey edges** link genes whose expression patterns are strongly correlated (|r| > threshold)

  - These edges show co-expression relationships, mapping the local structure of molecular coordination


- **Color encodes biological modules**: Cytokine, Interferon, and Metabolic — allowing us to see whether genes cluster by known functional groupings


- **Node size** represents hubness (degree)

  - Larger nodes are genes that co-vary with many others and may act as key regulators or integrators of biological signals


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

# install.packages(c("tidyverse", "igraph", "ggraph"))  # if needed

library(tidyverse)
set.seed(2025)

# ---------- Simulate Data ----------
n  <- 40
p  <- 15
genes <- paste0("Gene_", LETTERS[1:p])
mod1 <- 1:5; mod2 <- 6:10; mod3 <- 11:15

z1 <- rnorm(n); z2 <- rnorm(n); z3 <- rnorm(n)
expr <- matrix(rnorm(n * p, sd = 0.35), nrow = n, ncol = p)
colnames(expr) <- genes
expr[, mod1] <- expr[, mod1] + 1.2*z1
expr[, mod2] <- expr[, mod2] + 1.2*z2
expr[, mod3] <- expr[, mod3] + 1.2*z3

# ---------- correlations & adaptive threshold ----------
C <- cor(expr)
diag(C) <- 0
abs_r <- abs(C[upper.tri(C)])

# primary threshold from the 70th percentile (tweak if you like)
thr <- unname(quantile(abs_r, 0.70))

edges <- as.data.frame(as.table(C)) |>
  rename(from = Var1, to = Var2, r = Freq) |>
  filter(from < to, abs(r) >= thr)

# if still no edges, build k-nearest neighbor edges (k = 2)
if (nrow(edges) == 0) {
  k <- 2
  combs <- lapply(seq_len(p), function(i){
    rr <- abs(C[i, ])
    rr[i] <- -Inf
    nbrs <- names(sort(rr, decreasing = TRUE))[seq_len(k)]
    tibble(from = colnames(C)[i], to = nbrs, r = C[i, nbrs])
  }) |> list_rbind()

  edges <- combs |>
    rowwise() |>
    mutate(a = min(from, to), b = max(from, to)) |>
    ungroup() |>
    distinct(a, b, .keep_all = TRUE) |>
    transmute(from = a, to = b, r)
}

# ---------- layout via MDS ----------
D <- 1 - abs(C); D[D < 0] <- 0
coords <- cmdscale(as.dist(D), k = 2)

nodes <- tibble(
  gene = rownames(coords),
  x = coords[,1],
  y = coords[,2],
  module = case_when(
    gene %in% genes[mod1] ~ "Cytokine",
    gene %in% genes[mod2] ~ "Interferon",
    TRUE                  ~ "Metabolic"
  )
)

# ---------- node degree ----------
deg <- edges |>
  select(from, to) |>
  pivot_longer(everything(), values_to = "gene") |>
  count(gene, name = "degree")

nodes <- nodes |>
  left_join(deg, by = "gene") |>
  mutate(degree = replace_na(degree, 0))

# join edge coordinates
edges_plot <- edges |>
  left_join(nodes, by = c("from" = "gene")) |>
  rename(x_from = x, y_from = y) |>
  left_join(nodes, by = c("to" = "gene")) |>
  rename(x_to = x, y_to = y) |>
  mutate(alpha = scales::rescale(abs(r), to = c(0.25, 1)))

# ---------- plot ----------
ggplot() +
  # solid grey edges
  geom_segment(
    data = edges_plot,
    aes(x = x_from, y = y_from, xend = x_to, yend = y_to, alpha = alpha),
    color = "grey60", linewidth = 0.8
  ) +
  # nodes
  geom_point(
    data = nodes,
    aes(x = x, y = y, color = module, size = degree)
  ) +
  geom_text(
    data = nodes,
    aes(x = x, y = y, label = gene),
    vjust = -1, size = 3
  ) +
  scale_alpha(range = c(0.25, 1), guide = "none") +
  scale_size_continuous(range = c(3, 8)) +
  scale_color_brewer(palette = "Set2") +
  coord_equal() +
  theme_void(base_size = 13) +
  labs(
    title = "Simulated Gene Co-expression Network",
    subtitle = paste0("Solid edges = strong correlations (thr ≈ ", round(thr, 2),
                      ") \n color = biological module \n size = hubness")
  )




```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>



<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Data Visualization for Gene Co-expression Networks</span> {.smaller}


::: columns
::: {.column .small}

**Plot Interpretation**:

- **Green cluster - cytokine cluster**:

Genes likely to coordinate inflammatory communication between cells


- **Orange cluster - interferon cluster**:

Genes co-activated as part of the antiviral defense response, typically regulated by interferon pathways


- **Blue cluster - metabolic cluster**:

Genes whose expression reflects shared metabolic or energy-regulation processes, providing the cellular resources needed to sustain immune activity


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

# install.packages(c("tidyverse", "igraph", "ggraph"))  # if needed

library(tidyverse)
set.seed(2025)

# ---------- Simulate Data ----------
n  <- 40
p  <- 15
genes <- paste0("Gene_", LETTERS[1:p])
mod1 <- 1:5; mod2 <- 6:10; mod3 <- 11:15

z1 <- rnorm(n); z2 <- rnorm(n); z3 <- rnorm(n)
expr <- matrix(rnorm(n * p, sd = 0.35), nrow = n, ncol = p)
colnames(expr) <- genes
expr[, mod1] <- expr[, mod1] + 1.2*z1
expr[, mod2] <- expr[, mod2] + 1.2*z2
expr[, mod3] <- expr[, mod3] + 1.2*z3

# ---------- correlations & adaptive threshold ----------
C <- cor(expr)
diag(C) <- 0
abs_r <- abs(C[upper.tri(C)])

# primary threshold from the 70th percentile (tweak if you like)
thr <- unname(quantile(abs_r, 0.70))

edges <- as.data.frame(as.table(C)) |>
  rename(from = Var1, to = Var2, r = Freq) |>
  filter(from < to, abs(r) >= thr)

# if still no edges, build k-nearest neighbor edges (k = 2)
if (nrow(edges) == 0) {
  k <- 2
  combs <- lapply(seq_len(p), function(i){
    rr <- abs(C[i, ])
    rr[i] <- -Inf
    nbrs <- names(sort(rr, decreasing = TRUE))[seq_len(k)]
    tibble(from = colnames(C)[i], to = nbrs, r = C[i, nbrs])
  }) |> list_rbind()

  edges <- combs |>
    rowwise() |>
    mutate(a = min(from, to), b = max(from, to)) |>
    ungroup() |>
    distinct(a, b, .keep_all = TRUE) |>
    transmute(from = a, to = b, r)
}

# ---------- layout via MDS ----------
D <- 1 - abs(C); D[D < 0] <- 0
coords <- cmdscale(as.dist(D), k = 2)

nodes <- tibble(
  gene = rownames(coords),
  x = coords[,1],
  y = coords[,2],
  module = case_when(
    gene %in% genes[mod1] ~ "Cytokine",
    gene %in% genes[mod2] ~ "Interferon",
    TRUE                  ~ "Metabolic"
  )
)

# ---------- node degree ----------
deg <- edges |>
  select(from, to) |>
  pivot_longer(everything(), values_to = "gene") |>
  count(gene, name = "degree")

nodes <- nodes |>
  left_join(deg, by = "gene") |>
  mutate(degree = replace_na(degree, 0))

# join edge coordinates
edges_plot <- edges |>
  left_join(nodes, by = c("from" = "gene")) |>
  rename(x_from = x, y_from = y) |>
  left_join(nodes, by = c("to" = "gene")) |>
  rename(x_to = x, y_to = y) |>
  mutate(alpha = scales::rescale(abs(r), to = c(0.25, 1)))

# ---------- plot ----------
ggplot() +
  # solid grey edges
  geom_segment(
    data = edges_plot,
    aes(x = x_from, y = y_from, xend = x_to, yend = y_to, alpha = alpha),
    color = "grey60", linewidth = 0.8
  ) +
  # nodes
  geom_point(
    data = nodes,
    aes(x = x, y = y, color = module, size = degree)
  ) +
  geom_text(
    data = nodes,
    aes(x = x, y = y, label = gene),
    vjust = -1, size = 3
  ) +
  scale_alpha(range = c(0.25, 1), guide = "none") +
  scale_size_continuous(range = c(3, 8)) +
  scale_color_brewer(palette = "Set2") +
  coord_equal() +
  theme_void(base_size = 13) +
  labs(
    title = "Simulated Gene Co-expression Network",
    subtitle = paste0("Solid edges = strong correlations (thr ≈ ", round(thr, 2),
                      ") \n color = biological module \n size = hubness")
  )




```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>




## <span style="font-size:80%">Connecting Statistical Output to Biological Interpretation in High-Dimensional Data Analysis</span> {.smaller}


High-dimensional data analysis can produce thousands of statistical results: differential expression tests, feature correlations, variant associations numbers to interpret directly

Visualization transforms this statistical matrix into visual reasoning using the following approaches:

- Pathways $\rightarrow$ What biological programs explain this pattern?

  - Once subsections of data are visible, mapping them to pathways or ontologies connects the statistical pattern to biological mechanism — turning feature clusters into interpretable processes

  - Example: module corresponds to a T-cell activation pathway / metabolic shift



::: footer

:::



## <span style="font-size:80%">Pathway Level Analysis: Organizing Thousands of Tests</span> {.smaller}


- Organize results into interpretable biological systems

- Data visualization strategies to transform tabular data containing significant genes into visual structures

- Visual aggregation = clarity: grouping results by pathways (GO, KEGG, Reactome)

::: footer

:::



## <span style="font-size:80%">Pathway Level Analysis: Organizing Thousands of Tests</span> {.smaller}


- After running biomedical analysis - differential expression, epigenetic analysis, proteomics - obtain thousands of significant hits

- Raw tables of p-values offer no biological clarity—HD data must be grouped into interpretable themes

- Pathway level analysis moves from individual gene results (micro-level) to systems-level meaning (macro-level)


::: footer

:::


## <span style="font-size:80%">Pathway Level Analysis: Organizing Thousands of Tests</span> {.smaller}

Visual aggregation reveals biological programs, not individual genes

HD pathway level visualization types:

- **Dot plots** $\rightarrow$ summarize enrichment significance and effect size across pathways

- **Enrichment maps** $\rightarrow$ network-style visuals linking related functions (e.g., immune signaling $\leftrightarrow$ cytokine response)

- **Network graphs** $\rightarrow$ reveal cross-talk between processes, bridging molecular and clinical insight


::: footer

:::



## <span style="font-size:80%">Pathway Level Analysis: Organizing Thousands of Tests</span> {.smaller}

**Research Question**: Which biological pathways exhibit coordinated shifts in gene expressio, and how does the gene ratio (overlap / pathway size) highlight the relative strength of each pathway’s activation?

**Data [simulated]**: 

  - 3,000 genes with expression changes [log-fold changes] and p-values

  - Biological processes drawn from KEGG/Reactome/GO

::: footer

:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Pathway Level Analysis: Organizing Thousands of Tests</span> {.smaller}


::: columns
::: {.column .small}

**Plot**:

  - Pathway enrichment dot plot

  - Plot summarizes thousands of statistical tests into a small number of interpretable biological themes

**Plot Interpretation**

  - Row $\rightarrow$ pathway

  - Dot $\rightarrow$ level of pathway enrichment in the data
:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

# ---------------------------
# Pathway Enrichment Dot Plot with Uniform Color (Simulated Data)
# ---------------------------
library(tidyverse)

set.seed(7)

# 1) Simulate differential expression results
n_genes <- 3000
genes   <- paste0("G", seq_len(n_genes))

# effect sizes + p-values: mixture of null + signal
logFC <- rnorm(n_genes, 0, 0.6)
is_sig <- rbinom(n_genes, 1, prob = plogis(abs(logFC) - 1.0))  
pval <- ifelse(is_sig == 1, runif(n_genes, 1e-6, 0.01), runif(n_genes, 0.05, 1))

de <- tibble(gene = genes, logFC = logFC, pval = pval) |>
  mutate(fdr = p.adjust(pval, method = "BH"))

# "Selected" genes (e.g., DE at FDR < 0.05)
sel <- de |> filter(fdr < 0.05) |> pull(gene)

# 2) Realistic pathway names (common KEGG/Reactome/GO labels)
pathways <- c(
  "Interferon Alpha/Beta Signaling",
  "Interferon Gamma Signaling",
  "Cytokine Signaling in Immune System",
  "TNF Signaling Pathway",
  "NF-kappaB Signaling Pathway",
  "T Cell Receptor Signaling",
  "B Cell Receptor Signaling",
  "Antigen Processing and Presentation",
  "JAK-STAT Signaling Pathway",
  "Chemokine Signaling Pathway",
  "Complement Cascade",
  "Toll-like Receptor Signaling",
  "MAPK Signaling Pathway",
  "PI3K-Akt Signaling Pathway",
  "p53 Signaling Pathway",
  "Apoptosis",
  "Cell Cycle",
  "DNA Repair",
  "Oxidative Phosphorylation",
  "Glycolysis / Gluconeogenesis",
  "Fatty Acid Beta-Oxidation",
  "mTOR Signaling Pathway",
  "HIF-1 (Hypoxia) Signaling",
  "Unfolded Protein Response",
  "Autophagy",
  "ER Stress Response",
  "Notch Signaling",
  "Wnt Signaling",
  "Hedgehog Signaling",
  "Angiogenesis"
)

# Assign realistic pathway sizes (30–200 genes) and build gene sets
set_sizes <- sample(30:200, length(pathways), replace = TRUE)
gene_sets <- lapply(set_sizes, function(k) sample(genes, k))

# 3) ID over-representation test (Fisher's exact) per pathway
universe <- length(genes)
k_sel    <- length(sel)

enrich <- map2_dfr(pathways, gene_sets, function(path, set_genes) {
  k_in_set     <- length(intersect(set_genes, sel))
  set_size     <- length(set_genes)
  k_not_in_set <- k_sel - k_in_set
  not_set_size <- universe - set_size

  mat <- matrix(c(k_in_set, k_not_in_set,
                  set_size - k_in_set, not_set_size - k_not_in_set), nrow = 2)
  p <- fisher.test(mat, alternative = "greater")$p.value

  tibble(
    pathway = paste0(path, " (n=", set_size, ")"),
    set_size = set_size,
    overlap = k_in_set,
    p = p,
    gene_ratio = k_in_set / set_size
  )
})

enrich <- enrich |>
  mutate(fdr = p.adjust(p, method = "BH")) |>
  arrange(fdr, desc(gene_ratio)) |>
  slice_head(n = 20)

# 4) Plot
ggplot(enrich, aes(x = gene_ratio, y = reorder(pathway, gene_ratio))) +
  geom_point(aes(size = overlap), color = "#2A76DD") +   # same blue for all dots
  scale_size_continuous(name = "Overlap (genes)", breaks = pretty(enrich$overlap)) +
  labs(
    title = "Pathway Enrichment Dot Plot (Uniform Color)",
    subtitle = "X = Gene Ratio (overlap/size); all dots same color; size = overlapping genes",
    x = "Gene Ratio (overlap / pathway size)", y = "Pathway"
  ) +
  theme_minimal(base_size = 12) +
  theme(panel.grid.minor = element_blank())



```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

































## <span style="font-size:80%"></span> {.smaller}

::: columns
::: {.column width="70%"}
![](images/figure_1.jpg){.border .border-thick}
:::

::: {.column width="0%"}


::: incremental


:::
:::

:::
::: footer
:::





## <span style="font-size:80%"></span> {.smaller}

::: columns
::: {.column width="70%"}
![](images/figure_2_patient.png){.border .border-thick}
:::

::: {.column width="0%"}


::: incremental


:::
:::

:::
::: footer
:::


## <span style="font-size:80%"></span> {.smaller}

::: columns
::: {.column width="70%"}
![](images/figure_3_data.png){.border .border-thick}
:::

::: {.column width="20%"}
$\gg$

::: incremental


:::
:::

:::
::: footer
:::




## Lecture Outline


- Understanding what numeric data represent

- Visualizing numeric meaning - how quantities appear when plotted

- Visualization design depends on variable type, measurement scale, and clinical relevance



::: footer

:::




## <span style="font-size:80%">Understanding what numeric data represent</span> {.smaller}


- Quantitative variables describe measurable aspects of biology and clinical care

- Continuous vs. discrete values

- Biomedical anchoring: numbers derive meaning from context




::: footer

:::


## <span style="font-size:80%">Understanding what numeric data represent</span> {.smaller}

**Quantitative variables describe measurable aspects of biology and clinical care**

Numbers encode a measurable aspect of physiology, disease progression, or system performance

- Intensity — reflects a level at a given point in time

  - Example: fasting glucose (mg/dL) captures the concentration of circulating glucose in the blood at a moment


- Magnitude — reflects how much of something exists or is expressed


  - Example: HbA1c (%) indicates the cumulative magnitude of glucose exposure over months — it quantifies chronic metabolic burden


- Duration — measures how long an event, exposure, or state persists


  - Example: weeks on therapy or months since diagnosis track persistence of intervention or disease


- Rate — quantifies the speed of change per unit time


  - Example: ΔHbA1c per month indicates how rapidly glycemic control is improving or worsening




::: footer

:::




## <span style="font-size:80%">Understanding what numeric data represent</span> {.smaller}

**Continuous vs. Discrete Values**

Not all numeric variables behave the same way visually or statistically

- Continuous variables — can take on any value within a range

  - Example: fasting glucose can be 89.7 or 90.3 mg/dL — continuity matters for pattern recognition and precision

  - Visual implication: continuous values are best shown through smooth scales — histograms, scatterplots, line charts

- Discrete variables — represent countable categories or fixed levels

  - Example: therapy dose (0, 5, 10, 20 mg) or visit count (1, 2, 3)

  - Visual implication: use spacing or grouping — bar charts, dot plots, or step plots — to preserve discrete jumps

::: footer
:::



## <span style="font-size:80%">Understanding what numeric data represent</span> {.smaller}

**Clinical Anchoring: Numbers Derive Meaning from Context**

A numeric value only gains interpretive power when anchored to clinical or biological reference
Without context, numbers are meaningless 

With context numbers convey risk, efficacy, or progress

- Example: an HbA1c of 9.5% means “poor glycemic control” because clinicians know normal is <7%

- Example: a 1.5% reduction in HbA1c after 12 weeks signals clinically meaningful improvement, not merely statistical change

- Context transforms numeric data into decision-relevant evidence — what’s “normal,” what’s “effective,” what’s “concerning”

::: footer
:::



## <span style="font-size:80%">Example: Understanding Magnitude</span> {.smaller}


*Research Question*: How much does mean HbA1c decline across treatment arms after 12 weeks of therapy?

*Reminder*: HbA1c - Hemoglobin A1c 

- Protein found in blood 

- Formed when glucose (sugar) in the blood attaches to hemoglobin

- Measure of blood sugar levels


::: footer
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Example: Understanding Magnitude</span> {.smaller}


::: columns
::: {.column .small}

**Plot Type**: Bar chart 

- Encodes numeric magnitude by length from baseline

- Plot for comparing independent groups

**Rationale:**

- Bar charts emphasize group-level change at a fixed endpoint 

- Tool to visualize therapeutic efficacy in a clinical trial


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

library(tidyverse); set.seed(1)

df <- tibble(
  treatment = c("Placebo", "Low Dose", "High Dose"),
  mean_hba1c = c(-0.2, -0.8, -1.5),
  se = c(0.1, 0.15, 0.2)
)

ggplot(df, aes(x = treatment, y = mean_hba1c)) +
  geom_col(fill = "#68ccc4") +
  geom_errorbar(aes(ymin = mean_hba1c - se, ymax = mean_hba1c + se), width = 0.2) +
  labs(title = "Mean HbA1c Reduction After 12 Weeks", y = "Δ HbA1c (%)") +
  theme_minimal(base_size = 13)




```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>




## <span style="font-size:80%">Review: Encoding Numbers for Perception</span> {.smaller}

**What “Encoding” Means in Visualization**

- Encoding is the act of converting a numeric value into a visual variable that the human visual system can interpret

- It is how quantitative evidence becomes visible: position, length, area, color, slope, or angle

- Encoding sits at the intersection of measurement and cognition

::: footer
:::



## <span style="font-size:80%">Review: Encoding Numbers for Perception</span> {.smaller}


::: columns
::: {.column width="50%" style="font-size: 15pt;"}
**What “Encoding” Means in Visualization**

- Not all encodings convey numeric magnitude equally well

- Use position when precision matters

- Use color or area when conveying broad patterns or categorical context

- Pattern recognition or classification: color or area can add secondary structure
:::

::: {.column width="10%" style="font-size: 15pt;"}
| Encoding | Use Case     |
|-----------|--------------|
| `Position` | Continuous quantitative comparison (scatter, line, dot plots) |
| `Length` | Comparing magnitudes from a common zero (bars, lollipops) |
| `Angle/Slope` | Change, ratio, or trend (lines, radar charts) |
| `Area/Volume` | Expressing relative scale, emphasis, or uncertainty (bubbles, heatmaps) |
| `Color (Hue/Intensity)` | Differentiating groups or encoding ordinal ranges |
:::

:::
::: footer
:::



## <span style="font-size:80%">Example: Dose–Response Relationship</span> {.smaller}

*Research Question*: Is greater medication dose associated with larger HbA1c reduction?

Reminder:

Visual encoding transforms numbers into perceptual form

Position and length $\rightarrow$ precise

color or area $\rightarrow$ approximate but add context


::: footer
:::



<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Dose–Response Relationship</span> {.smaller}


::: columns
::: {.column .small}

**Plot Type**: scatter plot

- Encodes paired quantitative variables

- Ideal for examining dose–response

**Rationale**:

Reveals correlation, variability, and trend direction between two continuous measures


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

set.seed(2)
df <- tibble(
  dose_mg = runif(80, 0, 100),
  delta_hba1c = -0.2 - 0.015*dose_mg + rnorm(80, 0, 0.2)
)

ggplot(df, aes(dose_mg, delta_hba1c)) +
  geom_point(alpha = 0.6, color = "#4B9CD3") +
  geom_smooth(method = "lm", se = FALSE, color = "#1B9E77") +
  labs(title = "Dose–Response: HbA1c Change by Medication Dose",
       x = "Dose (mg)", y = "Δ HbA1c (%)") +
  theme_minimal(base_size = 13)


```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:80%">Visualizing Change: Numeric Trajectories </span> {.smaller}

- Longitudinal Numeric Data Reveal Process

- Line Plots Connect Sequential Measures

- Plots can help determine how fast and how persistently a biomarker changes


::: footer
:::


## <span style="font-size:80%">Visualizing Change: Numeric Trajectories </span> {.smaller}

Longitudinal Numeric Data Reveal Process

- Most biomedical observations are dynamic

- Single measurement : current state of an observation(i.e.: HbA1c value at week 12), reveals little about how 

- Longitudinal data :

  - multiple numeric observations over time 

  - captures the trajectory of change

::: footer
:::


## <span style="font-size:80%">Visualizing Change: Numeric Trajectories </span> {.smaller}

Line Plots Connect Sequential Measures

- Line plot : tool for visualizing numeric change over time or dose

- Each slope segment encodes rate of change:

  - Steep decline $\rightarrow$ rapid therapeutic response

  - Flat region $\rightarrow$ stability or steady state

  - Upturn $\rightarrow$ relapse or rebound

- Line direction and curvature make dynamic patterns perceptible at a glance

::: footer
:::




## <span style="font-size:80%">Visualizing Change: Numeric Trajectories </span> {.smaller}

Plots can help determine how fast and how persistently a biomarker changes

- Line trajectories show whether an intervention acts quickly, maintains response, or loses efficacy over time


::: footer
:::



## <span style="font-size:80%">Visualizing Change: Numeric Trajectories </span> {.smaller}

**Research question**: 

How does HbA1c evolve over 24 weeks among patients receiving low vs. high dose therapy?

**Plot Type**: Line plot 

- Connects repeated measurements per patient, summarizing time-dependent response

Reason for Selection:

- Depicts rate and pattern of change 


::: footer
:::



<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Visualizing Change: Numeric Trajectories</span> {.smaller}


::: columns
::: {.column .small}

**Research question**: 

How does HbA1c evolve over 24 weeks among patients receiving low vs. high dose therapy?

**Plot Type**: Line plot 

- Connects repeated measurements per patient, summarizing time-dependent response

**Reason for Selection**:

- Depicts rate and pattern of change 


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

library(tidyverse)
set.seed(4)

weeks <- 0:24
patients <- tibble(
  patient = paste0("P", 1:15),
  treatment = rep(c("Low Dose", "High Dose"), length.out = 15)
)

dat <- patients |>
  crossing(week = weeks) |>
  mutate(
    hba1c = 8 - if_else(treatment == "High Dose", 0.06, 0.03) * week + rnorm(n(), 0, 0.2)
  )

ggplot(dat, aes(week, hba1c, group = patient, color = treatment)) +
  geom_line(alpha = 0.5, linewidth = 0.9) +   # individual patients per treatment color
  stat_summary(
    fun = mean,
    geom = "line",
    linewidth = 1.5
  ) +                                          # mean line per group in matching color
  scale_color_manual(
    values = c("Low Dose" = "#6CA6CD", "High Dose" = "#1B9E77")
  ) +
  labs(
    title = "HbA1c Trajectories by Treatment Arm",
    subtitle = "Colored lines = individual patients; bold = mean trajectory per group",
    x = "Week",
    y = "HbA1c (%)",
    color = "Treatment"
  ) +
  theme_minimal(base_size = 13) +
  theme(legend.position = "top")


```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>




<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>

## <span style="font-size:60%">Visualizing Change: Numeric Trajectories</span> {.smaller}


::: columns
::: {.column .small}

**Interpretation**: 

- Each colored line represents one patient’s HbA1c (%) over 24 weeks of therapy
- Two treatment groups:
  - High Dose (green)
  - Low Dose (blue)
- Treatment effectiveness: both groups show a steady downward trend in HbA1c 
- High dose group: declines faster and reaches a lower mean HbA1c by Week 24
- Low dose group: shows a slower, smaller reduction 


:::
::: column

```{r}
#| fig-width: 8
#| fig-height: 9

library(tidyverse)
set.seed(4)

weeks <- 0:24
patients <- tibble(
  patient = paste0("P", 1:15),
  treatment = rep(c("Low Dose", "High Dose"), length.out = 15)
)

dat <- patients |>
  crossing(week = weeks) |>
  mutate(
    hba1c = 8 - if_else(treatment == "High Dose", 0.06, 0.03) * week + rnorm(n(), 0, 0.2)
  )

ggplot(dat, aes(week, hba1c, group = patient, color = treatment)) +
  geom_line(alpha = 0.5, linewidth = 0.9) +   # individual patients per treatment color
  stat_summary(
    fun = mean,
    geom = "line",
    linewidth = 1.5
  ) +                                          # mean line per group in matching color
  scale_color_manual(
    values = c("Low Dose" = "#6CA6CD", "High Dose" = "#1B9E77")
  ) +
  labs(
    title = "HbA1c Trajectories by Treatment Arm",
    subtitle = "Colored lines = individual patients; bold = mean trajectory per group",
    x = "Week",
    y = "HbA1c (%)",
    color = "Treatment"
  ) +
  theme_minimal(base_size = 13) +
  theme(legend.position = "top")


```
:::
:::


<style>
.tiny-table table { font-size: 0.8em; }        /* adjust as needed (0.8–0.9em) */
.tiny-table figcaption, .tiny-table .table-caption { font-size: 0.75em; }
</style>





## <span style="font-size:80%">Summary</span> {.smaller}

- Numerical representations :

  - quantitative variables describe measurable biological or clinical phenomena — intensity, magnitude, duration, or rate

  - meaning of numerical representations is context-dependent

- Visual encoding transforms numeric values into perceptual cues — position, length, angle, area, color, slope

- Numeric visualization converts raw quantitative data into perceptual evidence


::: footer
:::
